TrialJournal for immunotherapy of cancer2022

Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy.

Marta Casarrubios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.